[HTML][HTML] Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials …
The lack of standardized criteria for quantitative measurement of therapeutic response in
clinical trials poses a major obstacle for the development of new agents in chronic graft …
clinical trials poses a major obstacle for the development of new agents in chronic graft …
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood
Juvenile dermatomyositis, the most common inflammatory myopathy of childhood, is a rare
systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles …
systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles …
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, manual muscle testing (mmt) …
LG Rider, VP Werth, AM Huber… - Arthritis care & …, 2011 - Wiley Online Library
The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM),
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …
[PDF][PDF] 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory …
IE Lundberg, A Tjärnlund, M Bottai… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate new classification criteria for adult and juvenile idiopathic
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus
Monozygotic (MZ) twins are partially concordant for most complex diseases, including
autoimmune disorders. Whereas phenotypic concordance can be used to study heritability …
autoimmune disorders. Whereas phenotypic concordance can be used to study heritability …
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo‐phase trial
CV Oddis, AM Reed, R Aggarwal, LG Rider… - Arthritis & …, 2013 - Wiley Online Library
Objective To assess the safety and efficacy of rituximab in a randomized, double‐blind,
placebo‐phase trial in adult and pediatric myositis patients. Methods Adults with refractory …
placebo‐phase trial in adult and pediatric myositis patients. Methods Adults with refractory …
A novel autoantibody to a 155‐kd protein is associated with dermatomyositis
IN Targoff, G Mamyrova, EP Trieu… - … : Official Journal of …, 2006 - Wiley Online Library
Objective In polymyositis and dermatomyositis (DM), identified autoantibodies occur in<
50% of adult patients and in a smaller proportion of children. This study was undertaken as …
50% of adult patients and in a smaller proportion of children. This study was undertaken as …
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis …
Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis
(PM). Methods Expert surveys, logistic regression, and conjoint analysis were used to …
(PM). Methods Expert surveys, logistic regression, and conjoint analysis were used to …
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Background We describe the early experiences of adults with systemic rheumatic disease
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …
who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted …
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies
The juvenile idiopathic inflammatory myopathies (JIIM) are systemic autoimmune diseases
characterized by skeletal muscle weakness, characteristic rashes, and other systemic …
characterized by skeletal muscle weakness, characteristic rashes, and other systemic …